CH
HURA

CVI Holdings’s TuHURA Biosciences HURA Stock Holding History

CVI Holdings’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-108
Closed -$104K – 47
2019
Q3 		$104K Buy
+108
New +$203K 0.23% 23

Other funds holding HURA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

CVI Holdings's HURA Position: Q4 2019 in Review

CVI Holdings sold out of TuHURA Biosciences (HURA) in Q4 2019, closing a stake of 108 shares — an estimated $104K sold.

CVI Holdings first reported a position in HURA in Q3 2019 and held it in 1 quarter. The position peaked at $104K in Q3 2019. 8 funds tracked by Wall St. Rank hold HURA as of Q4 2019.

  • CVI Holdings reported no remaining TuHURA Biosciences position as of Q4 2019 after selling out during the quarter.
  • CVI Holdings sold 108 TuHURA Biosciences shares in Q4 2019, an estimated $104K.
  • CVI Holdings first reported a position in TuHURA Biosciences in Q3 2019 and held it in 1 quarter.
  • CVI Holdings's TuHURA Biosciences position peaked at $104K in Q3 2019.
  • 8 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2019.

Based on CVI Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.